Minerva Neurosciences | NERV - Créanciers Commerciaux

Prix De L'Action
6.55
Variation Quotidienne
-0.99 -13.13%
Mensuellement
4.80%
Annuel
254.05%
Q1 Prévisions
7.31




Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Adma Biologics USD 22.52M 1.5M 2025-12
ALKERMES USD 107.95M 39.95M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
AstraZeneca USD 25.28B 252M 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
J&J USD 11.99B 2.37B 2025-12
Merck USD 4.15B 102M 2025-09
Minerva Neurosciences USD 640K 305K 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novartis USD 4.46B 99M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 5.02B 142M 2025-09
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
Takeda JPY 467.59B 28.61B 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12